Evaluation of Piezocision Versus Injectable Platelet-rich Fibrin During Orthodontic Canine Retrac… (NCT07239024) | Clinical Trial Compass
By InvitationPhase 1
Evaluation of Piezocision Versus Injectable Platelet-rich Fibrin During Orthodontic Canine Retraction Orthodontic Canine Retraction: A Comparative Clinical Study
Egypt16 participantsStarted 2025-12-01
Plain-language summary
Comparison of piezocisin and injectable platelets rich fibrin during canine retraction
Who can participate
Age range14 Years – 22 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:. An age ranges from 14-22 years. 2. Crowding or protrusion that require 1st premolars extraction, followed by symmetrical canine retractions.
3\. All permanent teeth present, 3rd molars aren't considered. 4. Good oral hygiene. 5. No systemic disease and/or medication that could interfere with orthodontic tooth movement. 6. No previous orthodontic treatment. 7. No evidence of craniofacial anomalies, such as cleft lip and palate or previous history of trauma, bruxism, or parafunction. 8. No tooth size, shape, or root abnormalities visible on patient's radiographic records.
\-
Exclusion Criteria:Patients diagnosed to have an indication for non-extraction approach.
2\. Poor oral hygiene or periodontally compromised patient.
* 3\. Previous orthodontic treatment. 4. Any implanted assistive (e.g., pacemakers, cochlear implants, etc.). 5. Any skeletal dysplasia or craniofacial malformation. 6. Patients with root resorption, impacted canine or dental anomalies. 7. Any systemic diseases or medications that could interfere with orthodontic tooth movement.